![]() |
![]() |
![]() |
![]() |
office (404) 856-9157
toll-free (866) 692-6847
OTC Stock Review: Award Winning Small Cap Stock Picks Since 2004 |
![]() |
Qualigen Therapeutics, Inc. (NASDAQ: QLGN) is a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, as well as maintaining and expanding its core FDA-approved FastPack® System, which has been used in diagnostics for almost 20 years. The FastPack menu includes tests for cancer, men’s health, hormone function, vitamin D status and antibodies against SARS-CoV-2. The Company’s cancer therapeutics pipeline includes ALAN (AS1411-GNP), RAS-F and STARS™. ALAN (AS1411-GNP) is a DNA coated gold nanoparticle cancer drug candidate that has the potential to target various types of cancer with minimal side effects. | ||||||||||||||||||||
The foundational aptamer of ALAN, AS1411, is also being studied for use in treating or even preventing viral-based infectious diseases, including COVID-19. RAS-F is a family of RAS oncogene protein-protein interaction inhibitor small molecules for preventing mutated RAS genes’ proteins from binding to their effector proteins; preventing this binding could stop tumor growth, especially in pancreatic, colorectal and lung cancers. STARS is a DNA/RNA-based treatment device product candidate for removal from circulating blood of precisely targeted tumor-produced and viral compounds. Qualigen’s only products that are currently commercially available are its FastPack System diagnostic instruments and test kits. Qualigen’s facility in Carlsbad, California is FDA and ISO Certified and its FastPack product line is sold worldwide by its commercial partner Sekisui Diagnostics, LLC, or Sekisu. Read more about Qualigen Therapeutics, Inc. in our Report. |
|||||||||||||||||||||
![]() |
QSAM Bioscience, Inc. (QSAM) holds the worldwide license for CycloSam (Samaium-153 DOTMP), a clinical stage novel radiopharmaceutical meant to treat different types of bone cancer and related diseases. This isn’t just bone cancer. This drug could be used to treat OsteoSarcoma and Bone Metastasis. There has been no new treatment for OsteoSarcoma in the last 40 years. Forget about the fact that this is a billion dollar market. OsteoSarcoma and Bone Metastasis are both very common in Ewing Sarcoma, which is a cancerous tumor that grows in the bones, or in the tissue around bones, of children. The result is often amputation of the affected limb. QSAM could change this. |
||||||||||||||||||||
SAM is expecting to start the FDA approval process for CycloSam after the first of the year. The market cap on this company is much lower than just about every other company in the FDA approval process. QSAM will be looking for FDA approval on CycloSam as a chelate vehicle that carries the drug that can stop the growth of a tumor to the site of the growth. Read more about QSAM Bioscience in our Special Report.
|
|
Ring Energy, Inc.
(NYSEAmerican: REI) is a Midland, Texas-based oil
and gas exploration, development, and production company
with current operations in the Permian Basin of West Texas,
which is recognized as the top producing oil basin in North
America. Founded in 2012, the experienced management team
has aggressively sought to acquire select properties in the
Permian Basin with development opportunities for future
years. As of 12/31/18, the company has, through exploitation
and acquisitions, increased their proved reserves to an
estimated 36.6 million BOE’s (barrel of oil equivalents).
CEO Kelly Hoffman cut his teeth in the Permian Basin. He
started out there in 1975 with Amoco Production Company.
|
In the early 1990’s, Mr. Hoffman co-founded AOCO and drilled 60 wells in the Fuhrman Mascho field in Andrews, Texas. After 18 months and a 600% increase in revenue, AOCO sold the properties to Lomak (Range Resources). He did the same thing again in 1999 when he acquired 12,000 acres in Lubbock and Crosby counties. After drilling and completing 19 successful wells, he sold his interest in the property to Arrow Operating Company. My take is the management team at Ring Energy knows the Permian Basin very well. Read more about Ring Energy, Inc. in our Special Report.
|
ImageWare Systems, Inc. (OTCQB: IWSY) is a top developer of mobile and cloud-based multi-modal biometric identity management solutions, providing biometric, secure credential, and law enforcement technologies. After a bold start evolving silver halide photography into digital images, ImageWare built the first statewide digital booking platform for the United States law enforcement in 1998. Since then, ImageWare has evolved into the largest holder of multimodal biometrics, managing over 100 million identities daily. |
With vast experience in the
government sector, ImageWare is democratizing biometrics by
offering defense-grade identity and authentication solutions
to the masses. By identifying the person, not a device, and
never disclosing Personally Identifiable Information (PII),
ImageWare is giving populations around the globe access to
their important data. The company's biometric product line
is scalable for global deployment. ImageWare's biometric
product line includes a multi-biometric engine. This engine
is hardware and algorithm independent. This allows the
enrollment and management of unlimited population sizes.
ImageWare Systems is based in San Diego, California. Read more about
ImageWare Systems (IWSY) in our Special Report.
Information and Resources
FINRA's Daily List is a list of new issues, deleted issues, symbol and name changes, and other corporate actions for OTCBB and other-OTC securities. Read more.
OTC Markets daily list of Corporate Actions includes Symbol Changes, Marketplace/Tier Changes, Caveat Emptor Status Changes, Venue Changes, Ex-Dividends, Splits, Scheduled Dividends, Company Name Changes, Symbol & Name Changes, Suspensions/Halts, Deletions, Anticipated Piggybacks, and Piggyback Qualified issues. Read more.
OTCQX, OTCQB, OTC Pink, and Other OTC Most Active, biggest Advancers, and Biggest Decliners. Read more.
Recent Articles
Big-Name Executives and Celebrities Open Up Opportunities for
Retail Investors by Investing in Psychedelic Treatment as a
Means of Addressing Mental Health Crisis
ATLANTA, Dec. 08, 2020 (GLOBE NEWSWIRE) -- One day we are all
going to look back at psychedelic stocks and realize the
Grateful Dead was right. What a long strange trip it's been!
Psychedelic stocks...
December 08, 2020
Trends in Psychedelic Drugs Research and Four Stocks You Should
Know About
OTCStockReview.com News Commentary ATLANTA, Oct. 16, 2020 (GLOBE
NEWSWIRE) -- 2020 has been quite a year, but hidden among the
carnage is great news about advances in research on
psychedelic...
October 16, 2020
U.S. Small Cap Stocks Could Outperform The Market During The
Recovery And Here Are Four Stocks You Need To Know About
ATLANTA, July 22, 2020 (GLOBE NEWSWIRE) -- According to Premier
Miton Fund Manager Nick Ford in a recent CNBC’s “Squawk Box
Europe” interviewi, U.S. small cap stocks are set to outperform
the...
July 22, 2020
Four CBD Stocks For The Last Half Of 2020
ATLANTA, June 24, 2020 (GLOBE NEWSWIRE) -- CBD products have
gone mainstream and are now available in major retailers like
CVS, Walgreens, and Kroger. Over the past few years many
companies have...
June 24, 2020
Listen Up, These Hearing Aid Stocks Could Help Rebuild Your
Portfolio
OTCStockReview.com News Commentary ATLANTA, April 01, 2020
(GLOBE NEWSWIRE) -- Over the past three or four months, the news
coming out of Congress has been all about the coronavirus
pandemic,...
April 01, 2020
Tremendous Opportunities in Psychedelic Research are Beginning
to Garner Investor Attention
OTCStockReview.com News Commentary ATLANTA, Jan. 22, 2020 (GLOBE
NEWSWIRE) -- There is an uptrend in the research of psychedelic
substances for treating mental illnesses like addiction,...
January 22, 2020
OTC Stock Review Features Four CBD Stocks for 2020
ATLANTA, GA, Nov. 21, 2019 (GLOBE NEWSWIRE) -- CBD products are
becoming extremely popular as consumers discover the benefits of
cannabidiol in industries like cosmetics, health products, food
and...
November 21, 2019
My Case For Going Long Oil Stocks Read more.
Exclusive Snapchat: What You Need To Know Read more.
Exclusive Snap, Inc.: Why I'm Out On The Sidelines Read more.
Cannabis Sector Gains Traction On
President Trump’s Positive Comments On State’s Rights
Read more.
Trump Deregulation Creates Attractive Opportunities In Oil And
Gas Companies
Read more.